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SUmmAry
A case is presented of a patient with a skin basosquamous cell carcinoma of the frontal region infiltrating the cerebral tissue and with a 
widespread unresectable regional metastatic ulceration of the left parotid region. The patient underwent combined palliative treatment: sur-
gical coverage of the ulceration by means of a pectoralis mayor flap transposition and radiotherapy. After 18 months of follow-up, no signs 
of tumour progression were noted, the patient is currently free from pain, no increase in trismus was seen, and a slight gain in weight was 
recorded. Unresectable cancer is mainly treated by concurrent chemoradiation; radiotherapy, however, is contraindicated in deep neoplastic 
ulcerations with exposure of large vessels. The data reported suggest that surgical coverage of an unresectable neoplastic ulcer is feasible, 
and combined with early administration of radiation permits a palliative approach in an otherwise untreatable condition.
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riASSUnTo
Presentiamo il caso di un paziente con carcinoma basosquamoso della regione frontale arrivato alla nostra osservazione avendo già 
sviluppato un’estesa infiltrazione del tessuto cerebrale ed un’ampia ulcera metastatica laterocervicale sinistra non resecabile. Per poter 
offrire un trattamento palliativo al paziente abbiamo eseguito una copertura dell’ulcera neoplastica attraverso la trasposizione di un lembo 
miocutaneo di gran pettorale a cui ha fatto seguito radioterapia palliativa. Dopo 18 mesi di follow-up non sono stati riscontrati segni di 
progressione di malattia a livello loco-regionale, il paziente non ha dolore, il trisma non è aumentato e si è registrato un guadagno ponde-
rale. Le forme tumorali non resecabili vengono trattate con protocolli chemio-radioterapici; questi tuttavia sono controindicati in caso di 
ulcere profonde con esposizione dei grandi vasi. Il nostro caso clinico suggerisce che è tecnicamente possibile coprire efficacemente ulcere 
neoplastiche non resecabili ai fini di poter eseguire ulteriori trattamenti palliativi che devono necessariamente essere tempestivi. 
PArolE ChiAvE: Carcinoma squamocellulare • Chirurgia palliativa • Radioterapia palliativa • Tumore cutaneo • Cancro del distretto 
testa-collo
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Introduction
Basosquamous cell carcinoma (BSCC) is a rare malig-
nancy with features of both basal cell carcinoma (BCC) 
and squamous cell carcinoma (SCC) (Fig. 1). The recent 
world health organization (who) classification of head 
and neck tumours 1 defines BSCC as an aggressive sub-
type of SCC. The incidence of BSCC among BCC has 
been estimated to be 0.4-12% 2 and its higher metastatic 
propensity compared to SCC, is clearly highlighted in the 
literature 3 4. rare cases of BSCC with either leptomenin-
geal carcinomatosis 5 or infiltrating cerebral tissue 6 have 
been reported. disease onset usually occurs between the 
sixth and seventh decade, with the skin of the head and 
neck being the sites most involved. A more aggressive be-
haviour has been recorded in patients with recurrence, and 
male sex has been statistically correlated with likelihood 
of recurrence 7.
Palliative treatment in head and neck cancer aims to im-
prove the patient’s quality of life. in some cases, palliative 
treatment can prevent life-threatening complications (such 
as rupture of vessels) thus prolonging patient survival.
herewith the case is presented of a patient with BSCC of 
the supraorbital skin, infiltrating the cerebral tissue and 
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with widespread regional metastatic ulceration of the left 
parotid region. The patient underwent palliative treatment 
with surgical coverage and radiotherapy.
Case report
A 54-year-old male patient consulted our first aid unit on 
account of moderate bleeding from the neck. Upon physi-
cal examination, on the left side, a 3 × 2 cm non-bleeding 
ulceration of the frontal skin was found and a wide (ap-
proximately 10 × 5 cm) ulcer involving the left parotid 
area from the zygomatic arch to the level of the hyoid 
bone, eroding the external ear canal, disrupting most of 
the pavilion and causing complete peripheral facial nerve 
paralysis (Fig. 2). The patient also presented a moderate 
trismus with 1.5 cm maximal mouth opening. Upon visual 
inspection, it was possible to clearly perceive the carotid 
pulse at the jugulo-digastric level.
laboratory tests revealed a haemoglobin value of 12 mg/
dl with normal electroytes.
discussing the medical history, the patient reported hav-
ing undergone surgery abroad (Albania) for BCC of the 
frontal skin. Unfortunately, earlier detailed charts were 
not available, and relatives could not provide exhaustive 
information about previous surgical treatment. it was cer-
tain, however, that the patient had never received either 
radiotherapy or chemotherapy and that, abroad, no fur-
ther treatment options were advised besides pain control. 
From these findings, it was assessed that the disease ap-
peared 2 years before as a left-sided frontal skin lesion 
for which the patient had undergone local excision. Six 
months later, the patient developed a left parotid-cervical 
mass that was treated with parotidectomy and lymph-
node excision (no codified type of neck dissection was 
performed). Furthermore, 6 months after parotid-cervical 
surgery, a non-healing ulceration, which became progres-
sively enlarged, appeared in the parotid region with con-
comitant facial paralysis. moreover, a necrotic sore devel-
oped from the operated frontal skin. Since then the patient 
experienced progressive fatigue with consistent limitation 
in his daily activities, increasing pain that required mor-
phine patches, and weight loss (8 kg in the last 6 months). 
he never experienced either seizure or any other kind of 
cerebral symptom.
Contrast enhanced CT scan of the head and neck and 
thorax showed infiltration of the meningeal and cerebral 
tissue of the left frontal lobe, infiltration of the mastoid 
middle ear, complete encasement of the left internal and 
external carotid arteries with involvement of the pterygoid 
muscles and skull base (Fig. 3). no evidence of distant 
lung metastasis was observed. After appropriate counsel-
ling and multidisciplinary evaluation, the patient under-
went surgery. Extensive biopsies of the parotid ulcera-
tion’s borders were submitted for frozen section analysis 
that revealed BSCC (tumour staging rT4n1m0 8). The 
edges of the skin were resected until macroscopic healthy 
tissue was found. A generous undermining of the cervi-
cal skin, reaching the superior border of the clavicle, was 
carried out in order to avoid further incisions in the neck. 
A pectoralis major flap with a skin paddle of 20 × 8 cm 
was transposed to cover the defect. The external auditory 
canal was obliterated.
Fig. 1. Photomicrograph of the biopsy specimen (haematoxylin/eosin stain-
ing), showing basaloid cells and focal areas of squamous differentiation with 
keratinization.
Fig. 2. Pre-operative aspect of the left parotid region.
Fig. 3. Pre-operative CT scan. A: infiltration of the frontal bone and cerebral 
tissue. B: Involvement of the lateral pterygoid plate, tumour extension to the 
parapharyngeal space with encasement of the styloid process and internal 
carotid artery that lie close to the bottom of the ulcer.
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The post-operative course was uneventful, flap viability 
was optimal and no wound dehiscences occurred. The pa-
tient was discharged on the 4th post-operative day having 
been advised to undergo palliative radiotherapy that was 
started on the 15th day. External beam three-dimensional 
conformal radiotherapy was carried out using 6-mv pho-
tons (linear accelerator) equipment. Planning CT scan was 
performed in treatment position with a customized head 
mask. The gross tumour volume (gTv), the clinical target 
volume (CTv), the planning target volume (PTv) and the 
organs at risk (spinal cord, lens, eyes, etc.) were delineated 
on each slice. radiotherapy was delivered to the cervico-
parotid region with standard fractionation (2 gy per day, 
5 days a week) using three coplanar converging wedged 
beams (Fig. 4) and was stopped, at a total dose of 44 gy, 
when a neck abscess developed at the operated neck side. 
The abscess was treated with surgical evacuation by means 
of simple pen rose drain introduction and antibiotic admin-
istration. Since gTv, at this site, was strictly related to the 
spinal cord, it was not possible to achieve a higher total 
dose. The supraorbital frontal skin recurrence was treated 
with electron beam radiotherapy with standard fractiona-
tion until a total dose of 44 gy was reached.
Adjuvant chemotherapy was planned and advised, after 
the end of radiation, but the patient refused.
After 18 months of follow-up, no signs of tumour progres-
sion were noted, the patient is currently pain free, no in-
crease in trismus was observed, and a slight gain in weight 
was recorded (4 kg since the end of radiation) (Fig. 5).
Discussion
in the literature, there are no reports giving guidelines for 
the management of unresectable neoplastic head and neck 
ulcerations with vessel exposure.
Unresectable cancer is mainly treated by radiotherapy 
with comitant chemotherapy, the setting of which is de-
signed for a curative or a palliative intent based on the 
realistic chances of tumour control. Several host/tumour 
factors must be taken into consideration in treatment plan-
ning: patient’s general conditions (performance status) 
and specific comorbidities that might prevent withstand-
ing of the treatment, the possibility of delivering curative 
doses of radiation without damaging vital structures, the 
locoregional volumetric extension of the disease, the pres-
ence or absence of distant metastases.
in the present case, due to cerebral involvement, it was 
not possible to offer the patient a chemoradiation protocol 
with curative intent.
in the case presented, the need for surgical coverage arose 
from the evidence that radiotherapy is contraindicated in 
deep neoplastic ulcerations with exposure of great vessels, 
on account of the serious risk of blow-out with fatal haem-
orrhage. regional and distant tissue transfer techniques 
have increased the possibility of covering vital organs with 
well vascularised tissue allowing otherwise impossible ra-
diation delivery. nevertheless, we were unable to predict 
whether flap transposition would have efficiently covered 
the defect without dehiscence and without an immediate 
neoplastic colonization of the transposed tissue from the 
neoplastic recipient. This was our major concern, but we 
had to face the fact that no other options were available and 
that carotid rupture is such a catastrophic event that its expo-
sure represents a surgical priority in itself 9. we felt that the 
transposition of a pectoralis major flap was more appropri-
ate than reconstruction with a microvascular free flap, since 
the quality of the donor vessels for microvascular anasto-
mosis was questionable.
in head and neck cancer, it is recommended to start post-
operative adjuvant radiation, within 4-6 weeks after sur-
gery 10 to maximize loco-regional control. our prompt 
onset of post-operative radiation within 2 weeks after sur-
gery, despite the development of a neck abscess, might 
have been a crucial factor in successful palliation.
Even if, however, we obtained a pathologic assessment only 
of the parotid-neck ulceration, we believe that the frontal le-
sion had to be considered the primary tumour, while the pa-
rotid ulceration was the regional metastatic extension. Since 
the frontal ulceration appeared as a non-bleeding necrotic 
sore, we felt that it was not appropriate to take biopsies that Fig. 5. Post-operative result 18 months after palliative treatment.
Fig. 4. A: Planning CT scan, transversal dose distribution for three-dimen-
sional conformal radiation therapy, three wedged fields. B: Organs at risk and 
treatment volumes, three-dimensional three fields isodose reconstruction.
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could have worsened the local status and delayed the possi-
bility of radiation delivery. in fact, necrotic tissue frequent-
ly hides cancer proliferation, therefore thus preventing the 
diagnosis. This slight likelihood of obtaining the correct 
diagnosis with a single bite biopsy leads the surgeon physi-
cian to perform multiple biopsies that could jeopardize the 
clinical condition. Furthermore, confirmation histology of 
the primary lesion would not have changed our treatment 
strategy in this particular patient. in the sixth edition of 
the Tnm classification 8 (the only one available at the time 
the patient was treated), a giant unresectable metastatic in-
volvement of the neck and parotid was classified n1 like a 
single small lymph node metastasis. recently, in the sev-
enth edition of the Tnm classification 11, a more accurate n 
classification for non-melanoma skin cancer has been intro-
duced, accordingly our case would now be classified n3.: 
n0 no lymph node metastasis; n1 single < 3 cm; n2 single 
≥ 3 to 6 cm, multiple ≤ 6 cm; n3 > 6 cm. These changes 
certainly improve the hazard consistency (homogeneity 
within the group) and hazard discrimination (heterogeneity 
between the groups) of the classification. however, we feel 
that a further discrimination between resectable and unre-
sectable regional neck disease might be helpful, consider-
ing that treatment and prognosis of these conditions differ 
consistently. Furthermore, parotid disease, facial nerve in-
volvement and tumour size greater than ≥ 6 cm within the 
parotid, had less favourable prognosis in terms of survival 
in several studies 12-14.
Based on this concept, several years ago, a new staging 
system was introduced that separates parotid involve-
ment from cervical lymph node involvement 10-12. Parotid 
disease was more prognostic of poor survival than neck 
involvement; in particular, facial nerve involvement and 
tumour size ≥ 6 cm within the parotid 11 13. These studies 
were conducted on cutaneous SCC but probably the same 
findings might be valid also for BSCC.
Conclusions
in cases of unresectable neoplastic head and neck ul-
ceration, the combination of surgical coverage with post-
operative radiation radiotherapy offers a valid treatment 
option to achieve a palliation in an otherwise untreatable 
situation. This report indicates that surgical coverage of 
vital organs with well vascularised tissue is feasible even 
in the case of neoplastic recipient ulceration; the authors 
believe that, in these conditions, early administration of 
palliative radiation radiotherapy is mandatory.
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